Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

To DOAC or not DOAC: Special Patient Populations


.This activity is for pharmacists who want to adhere to safe use of direct oral anticoagulants in special patient populations

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
 
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

To encourage the safe use of direct oral anticoagulants in special patient populations.

Objectives

  • Identify existing literature on use of the direct oral anticoagulants in patients with antiphospholipid syndrome, cancer, and extremes of weight
  • Recall the pharmacokinetics and pharmacodynamic properties of the direct oral anticoagulants
  • Apply appropriate monitoring parameters for an agent, as necessary
  • Given a patient case, choose the appropriate agent to treat with consideration of supporting literature

Speaker(s)/Author(s)

David Parker picture

David Parker, PharmD
Shen


Brief Bio : Dr. David Parker is a PGY-1 Pharmacy Practice Resident at Winchester Medical Center. He is from Chesapeake, VA and obtained his doctor of pharmacy degree from Shenandoah University. His professional interests include internal medicine, infectious disease, and cardiology. He is a member of Kappa Psi Pharmaceutical Fraternty, Inc.

Activity Number

0101-0000-18-003-L01-P

Release Date: May 24, 2018
Credit Expiration Date: May 24, 2021

CE Hours

1.00

Location

HBP Room 109